|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.95 USD | +5.56% |
|
+1.57% | -75.77% |
Accelerate Diagnostics, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 12.75 million compared to USD 11.78 million a year ago. Net loss was USD 62.49 million compared to USD 77.7 million a year ago.
Basic loss per share from continuing operations was USD 7.6 compared to USD 12.6 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -75.77% | 19.5M | |
| +7.82% | 219B | |
| +7.42% | 184B | |
| +14.15% | 138B | |
| -0.95% | 62.54B | |
| +7.23% | 52.22B | |
| +12.94% | 51.73B | |
| +1.64% | 41.4B | |
| +4.90% | 37.17B | |
| +22.90% | 31.76B |
ACCELERATE DIAGNOSTICS, INC. 